ELAN · Healthcare
Elanco Animal Health Inc
24/100
Smart-money confidence1 of 3 sources positive
Bearish — money moving out
No standout activity across the feeds we track.
Hedge funds
32
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$11.1B
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Exchange
NYSE
About ELANCO ANIMAL HEALTH INC
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that…
Who's behind the signal
Every informed buyer we can see on ELAN, across all three feeds.
Hedge funds · 6
Citadel Advisors
Increased +19%
Gotham Asset Mgmt (Greenblatt)
Increased +122%
Bridgewater Associates (Dalio)
Increased +289%
D.E. Shaw & Co
Increased +24%
Millennium Management (Englander)
Decreased −91%
AQR Capital Management
Unchanged
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 8 on record
Disclosures from 2020-06-16 to 2022-04-13
The newest disclosure we hold for this stock is 2022-04-13.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-04-13 | Alan S. Lowenthal · D-CA | House | Sold | $1,001 - $15,000 |
| 2021-06-21 | Susie Lee · D-NV | House | Bought | $1,001 - $15,000 |
| 2021-06-10 | Susie Lee · D-NV | House | Bought | $1,001 - $15,000 |
| 2020-12-21 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-11-06 | Susie Lee · D-NV | House | Sold | $1,001 - $15,000 |
| 2020-11-05 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2020-10-22 | Katherine M. Clark · D-MA | House | Bought | $1,001 - $15,000 |
| 2020-06-16 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
ELANCO ANIMAL HEALTH INC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
0
New positions
4
Increasing
1
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+19%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
+122%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
+289%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+24%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−91%
0.0% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
—
0.0% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ELANCO ANIMAL HEALTH INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ELANCO ANIMAL HEALTH INC or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订